In particular, we show that BMMNC from Klf1(K74R) mice (Figure 2, Figure 2—figure supplement 1A) could confer 2-month-old WT recipient mice with the anti-cancer capability against melanoma. The gene discussed is KLF1; the disease is melanoma.